Home › Funds › BARINGS LLC › ONC
BARINGS LLC position in ONC
BEONE MEDICINES LTD · Health Care
BARINGS LLC reported holding 42,815 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$15.7M, representing 0.27% of its reported portfolio and ranking #38 among its reported holdings. BARINGS LLC has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BARINGS LLC's ONC position evolved
BARINGS LLC first disclosed a stake in ONC in Q4 2023 at 60,379 shares (US$10.9M). The position peaked in Q3 2025 at 55,604 shares, worth US$18.9M. Across 12 filings, BARINGS LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 42,815 shares valued at US$15.7M. Notable position changes include a 48% trim in Q1 2024 (shares fell 9% over the following quarter), a 66% increase in Q2 2024 (shares rose 57% over the following quarter), a 31% increase in Q3 2024 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 60.38K | $10.89M | New |
| Q1 2024 | 31.10K | $4.86M | Reduce |
| Q2 2024 | 51.76K | $7.39M | Add |
| Q3 2024 | 68.00K | $15.27M | Add |
| Q4 2024 | 71.42K | $13.19M | Add |
| Q1 2025 | 55.60K | $15.13M | Reduce |
| Q2 2025 | 55.60K | $13.46M | Hold |
| Q3 2025 | 55.60K | $18.94M | Hold |
| Q4 2025 | 42.81K | $13.01M | Reduce |
| Q1 2026 | 42.81K | $12.71M | Hold |
| Q2 2026 | 42.81K | $12.20M | Hold |
| Q3 2026 | 42.81K | $15.67M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 30 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 4.91M sh · $1.80B · Q3 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Candriam S.C.A. 289.24K sh · $106.23M · Q3 2026
- Capital International, Inc./CA/ 290.16K sh · $106.18M · Q3 2026
- Capital International Sarl 206.19K sh · $75.45M · Q3 2026
More on BARINGS LLC
FAQ
How long has BARINGS LLC held ONC?
BARINGS LLC has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is BARINGS LLC's current position in ONC?
As of Q3 2026, BARINGS LLC holds 42.81K shares of ONC (BEONE MEDICINES LTD), valued at $15.67M, representing 0.27% of its reported portfolio and ranking #38.
Has BARINGS LLC been buying or selling ONC?
In the latest 13F filing (Q3 2026), BARINGS LLC held unchanged its position in ONC. The position peaked in Q3 2025 at 55.60K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.